Virus Expression Database

GSE11348

Gene expression profiles during in vivo human rhinovirus infection: insights into the host response.

Submitted by Jay Patrick Tiesman (Procter & Gamble, USA) on May 05 2008

Platform: microarray – [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array

Pubmed: 18658112

Summary RATIONALE: Human rhinovirus infections cause colds and trigger exacerbations of lower airway diseases. OBJECTIVES: To define changes in gene expression profiles during in vivo rhinovirus infections. METHODS: Nasal epithelial scrapings were obtained before and during experimental rhinovirus infection, and gene expression was evaluated by microarray. Naturally acquired rhinovirus infections, cultured human epithelial cells, and short interfering RNA knockdown were used to further evaluate the role of viperin in rhinovirus infections. MEASUREMENTS AND MAIN RESULTS: Symptom scores and viral titers were measured in subjects inoculated with rhinovirus or sham control, and changes in gene expression were assessed 8 and 48 hours after inoculation. Real-time reverse transcription-polymerase chain reaction for viperin and rhinoviruses was used in naturally acquired infections, and viperin mRNA levels and viral titers were measured in cultured cells. Rhinovirus-induced changes in gene expression were not observed 8 hours after viral infection, but 11,887 gene transcripts were significantly altered in scrapings obtained 2 days postinoculation. Major groups of up-regulated genes included chemokines, signaling molecules, interferon-responsive genes, and antivirals. Viperin expression was further examined and also was increased in naturally acquired rhinovirus infections, as well as in cultured human epithelial cells infected with intact, but not replication-deficient, rhinovirus. Knockdown of viperin with short interfering RNA increased rhinovirus replication in infected epithelial cells. CONCLUSIONS: Rhinovirus infection significantly alters the expression of many genes associated with the immune response, including chemokines and antivirals. The data obtained provide insights into the host response to rhinovirus infection and identify potential novel targets for further evaluation.

93 Samples

ID Title Cell Type Timepoint Reported Virus Virus Species Exclusion Reason
GSM286646 Subject #8001-8hr Postinfection nasal mucosa  8 hrs RV16 Rhinovirus A
GSM286647 Subject #8001-Preinfection nasal mucosa  RV16 Uninfected
GSM286648 Subject #8001-2d Postinfection nasal mucosa  48 hrs RV16 Rhinovirus A
GSM286649 Subject #8002-8hr Postinfection nasal mucosa  8 hrs control Uninfected
GSM286650 Subject #8002-Preinfection nasal mucosa  control Uninfected
GSM286651 Subject #8002-2d Postinfection nasal mucosa  48 hrs control Uninfected
GSM286652 Subject #8007-8hr Postinfection nasal mucosa  8 hrs RV16 Rhinovirus A
GSM286653 Subject #8007-Preinfection nasal mucosa  RV16 Uninfected
GSM286654 Subject #8007-2d Postinfection nasal mucosa  48 hrs RV16 Rhinovirus A
GSM286655 Subject #8008-8hr Postinfection nasal mucosa  8 hrs control Uninfected
GSM286656 Subject #8008-Preinfection nasal mucosa  control Uninfected
GSM286657 Subject #8008-2d Postinfection nasal mucosa  48 hrs control Uninfected
GSM286658 Subject #8009-8hr Postinfection nasal mucosa  8 hrs control Uninfected
GSM286659 Subject #8009-Preinfection nasal mucosa  control Uninfected
GSM286660 Subject #8009-2d Postinfection nasal mucosa  48 hrs control Uninfected
GSM286661 Subject #8010-8hr Postinfection nasal mucosa  8 hrs control Uninfected
GSM286662 Subject #8010-Preinfection nasal mucosa  control Uninfected
GSM286663 Subject #8010-2d Postinfection nasal mucosa  48 hrs control Uninfected
GSM286664 Subject #8011-8hr Postinfection nasal mucosa  8 hrs control Uninfected
GSM286665 Subject #8011-Preinfection nasal mucosa  control Uninfected
GSM286666 Subject #8011-2d Postinfection nasal mucosa  48 hrs control Uninfected
GSM286667 Subject #8012-8hr Postinfection nasal mucosa  8 hrs RV16 Rhinovirus A
GSM286668 Subject #8012-Preinfection nasal mucosa  RV16 Uninfected
GSM286669 Subject #8012-2d Postinfection nasal mucosa  48 hrs RV16 Rhinovirus A
GSM286670 Subject #8013-8hr Postinfection nasal mucosa  8 hrs control Uninfected
GSM286671 Subject #8013-Preinfection nasal mucosa  control Uninfected
GSM286672 Subject #8013-2d Postinfection nasal mucosa  48 hrs control Uninfected
GSM286673 Subject #8015-8hr Postinfection nasal mucosa  8 hrs control Uninfected
GSM286674 Subject #8015-Preinfection nasal mucosa  control Uninfected
GSM286675 Subject #8015-2d Postinfection nasal mucosa  48 hrs control Uninfected
GSM286676 Subject #8017-8hr Postinfection nasal mucosa  8 hrs control Uninfected
GSM286677 Subject #8017-Preinfection nasal mucosa  control Uninfected
GSM286678 Subject #8017-2d Postinfection nasal mucosa  48 hrs control Uninfected
GSM286679 Subject #8018-8hr Postinfection nasal mucosa  8 hrs RV16 Rhinovirus A
GSM286680 Subject #8018-Preinfection nasal mucosa  RV16 Uninfected
GSM286681 Subject #8018-2d Postinfection nasal mucosa  48 hrs RV16 Rhinovirus A
GSM286682 Subject #8019-8hr Postinfection nasal mucosa  8 hrs RV16 Rhinovirus A
GSM286683 Subject #8019-Preinfection nasal mucosa  RV16 Uninfected
GSM286684 Subject #8019-2d Postinfection nasal mucosa  48 hrs RV16 Rhinovirus A
GSM286685 Subject #8022-8hr Postinfection nasal mucosa  8 hrs control Uninfected
GSM286686 Subject #8022-Preinfection nasal mucosa  control Uninfected
GSM286687 Subject #8022-2d Postinfection nasal mucosa  48 hrs control Uninfected
GSM286688 Subject #8023-8hr Postinfection nasal mucosa  8 hrs control Uninfected
GSM286689 Subject #8023-Preinfection nasal mucosa  control Uninfected
GSM286690 Subject #8023-2d Postinfection nasal mucosa  48 hrs control Uninfected
GSM286691 Subject #8024-8hr Postinfection nasal mucosa  8 hrs RV16 Rhinovirus A
GSM286692 Subject #8024-Preinfection nasal mucosa  RV16 Uninfected
GSM286693 Subject #8024-2d Postinfection nasal mucosa  48 hrs RV16 Rhinovirus A
GSM286694 Subject #8027-8hr Postinfection nasal mucosa  8 hrs control Uninfected
GSM286695 Subject #8027-Preinfection nasal mucosa  control Uninfected
GSM286696 Subject #8027-2d Postinfection nasal mucosa  48 hrs control Uninfected
GSM286697 Subject #8028-8hr Postinfection nasal mucosa  8 hrs RV16 Rhinovirus A
GSM286698 Subject #8028-Preinfection nasal mucosa  RV16 Uninfected
GSM286699 Subject #8028-2d Postinfection nasal mucosa  48 hrs RV16 Rhinovirus A
GSM286700 Subject #8030-8hr Postinfection nasal mucosa  8 hrs RV16 Rhinovirus A
GSM286701 Subject #8030-Preinfection nasal mucosa  RV16 Uninfected
GSM286702 Subject #8030-2d Postinfection nasal mucosa  48 hrs RV16 Rhinovirus A
GSM286703 Subject #8031-8hr Postinfection nasal mucosa  8 hrs control Uninfected
GSM286704 Subject #8031-Preinfection nasal mucosa  control Uninfected
GSM286705 Subject #8031-2d Postinfection nasal mucosa  48 hrs control Uninfected
GSM286706 Subject #8032-8hr Postinfection nasal mucosa  8 hrs RV16 Rhinovirus A
GSM286707 Subject #8032-Preinfection nasal mucosa  RV16 Uninfected
GSM286708 Subject #8032-2d Postinfection nasal mucosa  48 hrs RV16 Rhinovirus A
GSM286709 Subject #8034-Preinfection nasal mucosa  RV16 Uninfected
GSM286710 Subject #8034-2d Postinfection nasal mucosa  48 hrs RV16 Rhinovirus A
GSM286711 Subject #8034-8hr Postinfection nasal mucosa  8 hrs RV16 Rhinovirus A
GSM286712 Subject #8035-8hr Postinfection nasal mucosa  8 hrs RV16 Rhinovirus A
GSM286713 Subject #8035-Preinfection nasal mucosa  RV16 Uninfected
GSM286714 Subject #8035-2d Postinfection nasal mucosa  48 hrs RV16 Rhinovirus A
GSM286715 Subject #8037-8hr Postinfection nasal mucosa  8 hrs RV16 Rhinovirus A
GSM286716 Subject #8037-Preinfection nasal mucosa  RV16 Uninfected
GSM286717 Subject #8037-2d Postinfection nasal mucosa  48 hrs RV16 Rhinovirus A
GSM286718 Subject #8038-8hr Postinfection nasal mucosa  8 hrs RV16 Rhinovirus A
GSM286719 Subject #8038-Preinfection nasal mucosa  RV16 Uninfected
GSM286720 Subject #8038-2d Postinfection nasal mucosa  48 hrs RV16 Rhinovirus A
GSM286721 Subject #8039-8hr Postinfection nasal mucosa  8 hrs control Uninfected
GSM286722 Subject #8039-Preinfection nasal mucosa  control Uninfected
GSM286723 Subject #8039-2d Postinfection nasal mucosa  48 hrs control Uninfected
GSM286724 Subject #8040-8hr Postinfection nasal mucosa  8 hrs RV16 Rhinovirus A
GSM286725 Subject #8040-Preinfection nasal mucosa  RV16 Uninfected
GSM286726 Subject #8040-2d Postinfection nasal mucosa  48 hrs RV16 Rhinovirus A
GSM286727 Subject #8041-8hr Postinfection nasal mucosa  8 hrs RV16 Rhinovirus A
GSM286728 Subject #8041-Preinfection nasal mucosa  RV16 Uninfected
GSM286729 Subject #8041-2d Postinfection nasal mucosa  48 hrs RV16 Rhinovirus A
GSM286730 Subject #8042-8hr Postinfection nasal mucosa  8 hrs control Uninfected
GSM286731 Subject #8042-Preinfection nasal mucosa  control Uninfected
GSM286732 Subject #8042-2d Postinfection nasal mucosa  48 hrs control Uninfected
GSM286733 Subject #8045-8hr Postinfection nasal mucosa  8 hrs control Uninfected
GSM286734 Subject #8045-Preinfection nasal mucosa  control Uninfected
GSM286735 Subject #8045-2d Postinfection nasal mucosa  48 hrs control Uninfected
GSM286736 Subject #8046-8hr Postinfection nasal mucosa  8 hrs control Uninfected
GSM286737 Subject #8046-Preinfection nasal mucosa  control Uninfected
GSM286738 Subject #8046-2d Postinfection nasal mucosa  48 hrs control Uninfected